MTOR and hepatocellular carcinoma: These findings suggest that LncRNA TUG1/miR-144-3p/RRAGD/mTOR axis has a hand in the evovement of HCC and might serve a potential therapeutic target and provide novel biomarkers for HCC in the aspect of precise prevention, diagnosis and prognosis.